Darin Lippoldt - 13 Feb 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Legal Officer
Signature
Darin Lippoldt
Issuer symbol
NBIX
Transactions as of
13 Feb 2023
Net transactions value
$0
Form type
4
Filing time
15 Feb 2023, 18:13:02 UTC
Previous filing
08 Feb 2023
Next filing
23 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Stock Option Award $0 +51,782 $0.000000 51,782 13 Feb 2023 Common Stock 51,782 $103.52 Direct F1
transaction NBIX Restricted Stock Unit Award $0 +8,332 $0.000000 8,332 13 Feb 2023 Common Stock 8,332 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F3 The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027.